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Distinct selective forces and 
Neanderthal introgression shaped 
genetic diversity at genes involved 
in neurodevelopmental disorders
Alessandra Mozzi1, Diego Forni1, Rachele Cagliani1, Uberto Pozzoli  1, Mario Clerici2,3 & 
Manuela Sironi  1
In addition to high intelligence, humans evolved specialized social-cognitive skills, which are specifically 
affected in children with autism spectrum disorder (ASD). Genes affected in ASD represent suitable 
candidates to study the evolution of human social cognition. We performed an evolutionary analysis 
on 68 genes associated to neurodevelopmental disorders; our data indicate that genetic diversity was 
shaped by distinct selective forces, including natural selection and introgression from archaic hominins. 
We discuss the possibility that segregation distortion during spermatogenesis accounts for a subset 
of ASD mutations. Finally, we detected modern-human-specific alleles in DYRK1A and TCF4. These 
variants are located within regions that display chromatin features typical of transcriptional enhancers 
in several brain areas, strongly suggesting a regulatory role. These SNPs thus represent candidates for 
association with neurodevelopmental disorders, and await experimental validation in future studies.
In nature, “intelligence” can be defined as the problem-solving ability to adapt to changes in natural and social 
environment. In the last decades, broad comparative analyses indicated that social interaction drives the evolu-
tion of higher cognitive abilities in animals1, 2, supporting the “social brain hypotesis”3. Although complex social 
systems are observed throughout the animal kingdom, vertebrates are considered to posses higher cognitive func-
tions and more complex social behaviors than invertebrates4, 5. Recent studies suggest that vertebrate expansion in 
synapse proteome complexity, driven by the combined action of paralog diversification and alternative splicing, 
contributed to the behavioral and cognitive complexity of these species6, 7.
Among vertebrates, advanced cognitive abilities and complex behavioral patterns are observed in Mammalia 
and Aves. Within both classes, some lineages stand out for their higher cognition (e.g., primates, cetaceans, and 
elephants in mammals, corvids and parrots in birds)8–10. However, prosocial behaviors such as other-regarding 
preferences and reciprocity are thought to be more common in mammals compared to other vertebrates11, 12.
Among all animals, humans display the highest forms of intelligence, although uncertainty still exists about 
the timing of appearance of some cognitive and behavioral traits and on the sharing of these features with archaic 
extinct hominids13, 14. In modern humans, the evolution of cognitive functions led to the development of a gram-
matical and syntactical language, which has likely served as an intelligence amplifier15. Humans have also evolved 
specialized social-cognitive skills for living and exchanging knowledge in cultural groups16. Some of these skills 
are specifically affected in children with autism spectrum disorder (ASD). In fact, it was recently suggested13 that 
genes and cerebral circuits affected in ASD represent candidates for the evolution of human social cognition. 
Notably, it was proposed that the higher cognitive capacities in humans were acquired at the cost of increased 
susceptibility to mental disease17–19.
Psychiatric conditions such ASD and schizophrenia (SCZ) have a prevalence around 3–4% in human popula-
tions20. SCZ and ASD are characterized by a polygenic architecture and persist in populations despite a negative 
fitness effect. This apparent evolutionary paradox is explained by recent observations that, although common 
variants play a role in the pathogenesis of ASD and SCZ21, 22, rare or de novo mutations represent the major source 
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of large-effect risk factors23, 24. Substantial overlap exists among genes mutated in ASD/SCZ and those associated 
with intellectual disability (ID)24, 25. ID has an overall prevalence of 1.5 to 2% in Western populations and is com-
mon in children diagnosed with ASD25. Overall, these observations suggest that the expansion of cognitive and 
social abilities also expanded the mutational target for ASD, SCZ, and ID, thus explaining their high prevalence.
Because of the huge genetic heterogeneity of these complex diseases, a reverse strategy based on the iden-
tification of networks of genes interconnected by a specific feature (e.g. biological function or protein-protein 
interactions) may help define genetic disease subtypes26–28. Starting from these assumptions, we analyzed the 
evolutionary history of two gene modules (M1 and M2), that are associated with different phenotypes and were 
previously identified by Hormozdiari and colleagues29. These modules were built through the exome sequencing 
data of 1116 patients affected by ASD and ID29. Module 1 includes genes associated to transcriptional regulation 
during brain development, whereas module 2 is composed of synaptic genes involved in long-term potentiation 
and calcium signaling29.
Results
Gene selection. We analyzed the evolutionary history of two different sets of genes (modules M1 and M2) 
previously identified by Hormozdiari and colleagues using MAGI (Merging Affected Genes into Integrated-
networks)29. This computational method simultaneously integrates protein-protein interaction data, RNA 
expression profile, and the enrichment of de novo mutations in affected probands. Specifically, Hormozdiari and 
coworkers used expression data during brain development and de novo mutations from 6 studies of ASD and 
ID29. Each of these modules contains a subset of genes belonging to a common pathway. M1 consists of 47 genes 
associated with Wnt, Notch, SWI/SNF, and NCOR signaling, and showing high expression during embryonic 
development (8–16 pcw) (Fig. 1, Supplementary Table S1). M2 includes 21 genes associated with synaptic func-
tion and mainly expressed at postnatal stages (Fig. 1, Supplementary Table S1).
Figure 1. M1 and M2 gene networks. Interaction networks of module 1 (M1) an module 2 (M2) genes as 
obtained by Cytoscape, using the geneMANIA application.
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Episodic positive selection in Mammalia and Sauropsida. We first explored possible variations in 
selective pressure at M1 and M2 module genes among vertebrate species. In particular, we applied branch-site 
likelihood ratio tests (LRTs)30 to phylogenies that include representative vertebrate species from lamprey to 
human (Fig. 2, Supplementary Table S2). When recombination was detected, gene alignments were split on the 
basis of the recombination breakpoints.
LRTs were used to test the two internal branches of the phylogeny leading to the Mammalia and to the 
Sauropsida classes (Fig. 2). A false discovery rate (FDR) correction was applied, as suggested31. Positive selection 
was declared if neutral models were rejected in favor of the positive selection model using two codon frequency 
models (Table 1, Supplementary Table S3).
Evidence of positive selection was detected in 8/47 (17.0%) M1 genes and in 6/21 (28.6%) M2 genes (Table 1, 
Supplementary Table S3). Most genes with statistically-supported evidence of positive selection in mammals also 
showed evidence of selection in Sauropsida (Table 1, Supplementary Table S3). For instance, this was the case for 
MECP2, which causes Rett syndrome when mutated, and of SYNGAP1, whose mutations were associated with ID, 
ASD, and epilepsy32, 33. Three genes were only selected on the Sauropsida branch, and five only on the mammalian 
branch (Table 1). Overall, these data suggest that genes in the two modules were not targeted by stronger selective 
pressure in Mammalia compared to Sauropsida.
Positively selected sites along the mammalian or sauropsidan branches were identified through the Bayes 
Empirical Bayes (BEB) analysis30. To be conservative, we considered as positively selected only sites also detected 
by the Mixed Effects Model of Evolution (MEME) method34. Using this criterion, a few positively selected sites 
were detected (Table 1, Fig. 3). Interestingly, three sites positively selected on the mammalian branch are located 
in two genes encoding major components of the postsynaptic density (PSD) of excitatory neuronal synapses: 
GRIN2A and SYNGAP1. In particular, two sites (G951 and T1043) map to the C-terminal domain (CTD) of 
GRIN2A, and one (R329) is located in the SYNGAP1 C2 domain, which is necessary for the Rap GTPase activ-
ity35 (Fig. 3).
Positive selection across the mammalian phylogeny. The branch-site tests we applied in the section 
above are well-suited to search for episodic selection in a phylogeny of distantly related species36, but they are 
generally characterized by low statistical power30. Thus, for genes showing evidence of selection along the mam-
malian branch, we extended the evolutionary analysis to include additional species. The codeml site models37 
were run on gene phylogenies of at least 60 mammalian species (Table 2, Supplementary Tables S2 and S4). When 
recombination was detected, gene alignments were split on the basis of the recombination breakpoints. Two 
neutral models (M8a and M7) were rejected in favor of the M8 positive selection model for the MDM2, MECP2, 
MYC, SMARCC2, and UIMC1 genes in module 1, as well as for GRIN2A, MAP1A and SYNGAP1 in module 2 
(Table 2, Supplementary Table S4).
Figure 2. Vertebrata and mammalian phylogenies. Phylogenetic tree of the Vertebrata species used in our 
analyses. The mammalian and sauropsidan branches are highlighted in orange and green, respectively. The 
extended mammalian phylogeny is also reported on the right (Supplementary Table S2).
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BEB30, FUBAR (Fast Unconstrained Bayesian AppRoximation)38, and REL (Random effects likelihood)39 were 
used to identify selected sites. Again, only sites detected by at least two different methods were considered as 
selection targets (Table 2).
Using this approach, an additional selected site (P1150) was detected in the GRIN2A CTD. Several positively 
selected sites were found in MDM2 and UIMC1. In MDM2, most selected sites are located in a C-terminal region 
encompassing two Zinc-finger domains; in UIMC1, sites tend to be scattered across the protein sequence (Fig. 3). 
Two of them (L152 and F456) are in a region necessary for the interaction with NR6A140, a nuclear receptor with 
a role in neurogenesis41.
Among M2 genes, we identified 12 selected sites in MAP1A. This gene encodes a microtubule-associated 
protein predominantly expressed in neurons42. All selected sites are in the heavy-chain domain that cooper-
ates with the light-chain for microtubule binding43. In particular, four selected sites are located in the second 
microtubule-binding domain (Fig. 3). Interestingly, one positively selected site was also detected in SMARCC2, 
which encodes a subunit of the chromatin remodeling complex mSWI/SNF that directly controls neurogenesis in 
the developing cerebral cortex by regulating its size and thickness44.
Purifying and positive selection in humans and great apes. Taking advantage of the availability 
of genetic diversity data for humans and great apes, we combined analysis of intra-species polymorphism and 
between-species divergence to detect sites targeted by positive selection in the human, chimpanzee, and gorilla 
lineages. To this aim, we used the gammaMap method45, which categorizes population-scaled selection coef-
ficients (γ) into 12 classes, ranging from strongly beneficial (γ = 100) to inviable (γ = −500), with γ equal to 0 
indicating neutrality.
As expected, analysis of γ for M1 and M2 genes indicated a major role of purifying selection: most median 
values were lower than or equal to −50 (indicating that most amino acid replacements are deleterious) (Fig. 4). 
However, the degree of constraint was stronger in the gorilla and chimpanzee lineages compared to humans, 
especially for M1 genes (Fig. 4).
We also identified lineage-specific positively selected sites, defined as those with a cumulative probability 
higher than 0.75 of having γ ≥ 146 (Table 3). Positively selected sites were detected in genes showing higher 
median γ values, suggesting that these genes were targeted by positive selection, and did not merely experience a 
relaxation of constraint or accumulated rare variants as a result of human population size growth47 (Fig. 4).
Purifying selection in human populations. Given the major effect of purifying selection in driving the 
evolution of M1 and M2 genes, we next compared their level of constraint to that imposed on other human 
genes. To this purpose, we used SnIPRE, which contrasts polymorphism and divergence data at nonsynony-
mous and synonymous sites, to calculate the constraint parameter f. f represents the proportion of mutations 
that are non-lethal. Thus, the lower f is for a given gene, the stronger its level of constraint48. f values were cal-
culated for genes in modules 1 and 2, as well as for all human RefSeq autosomal coding genes (see Materials 
Mammalia Sauropsida
(MA1−MA) 
−2ΔlnLa p valueb
MEME-BEB 
sitesc
(MA1−MA) 
−2ΔlnLa p valueb
MEME-BEB 
sitesc
M1
CHD8 58.044 2.56 × 10−14 — 76.290 4.90 × 10−18 D2199, D2487
HSPA4 0 1 — 11.0829 1.74 × 10−3 —
MDM2 12.255 9.28 × 10−4 L205 0 1 —
MECP2 4.950 2.61 × 10−2 — 21.963 5.56 × 10−6 —
MYC 10.527 2.35 × 10−3 — 8.519 3.51 × 10−3 —
RB1 0 1 — 15.493 1.66 × 10−4 —
SMARCC2 
Region 2 
(106–1152aa)
15.721 1.47 × 10−4 — 0 1 —
UIMC1 7.634 7.85 × 10−3 — 7.068 7.85 × 10−3 —
M2
DLG4 5.320 4.22 × 10−2 — 0 1 —
GRIN2A Region 
3 (867–1464aa) 5.974 1.73 × 10
−2 G951, T1043 5.667 1.73 × 10−2 —
GRIN2B 0 1 — 8.337 7.77 × 10−3 —
KCNMA1 18.850 1.44 × 10−5 — 18.811 1.44 × 10−5 C622
MAP1A 61.374 9.44 × 10−15 L610, S1029, G2436 32.349 1.29 × 10
−8 —
SYNGAP1 
Region 2 
(115–1343aa)
64.996 1.50 × 10−15 R329, A1281 26.360 2.83 × 10−7 —
Table 1. Likelihood ratio test statistics for models of variable selective pressure along mammalian and 
sauropsidan branches (codon frequency:F3 × 4). a2ΔlnL: twice the difference of the natural logs of the 
maximum likelihood of the models being compared. bp values are FDR corrected. cPositions refer to the human 
sequence (see Supplementary Table 1, Supplementary material). Bolded p-values indicated LRTs confirmed by 
appling the F61 codon frequency model (see Supplementary Table 1, Supplementary material).
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and Methods). The distribution of f values was significantly different in the three groups (one-way ANOVA, 
F = 39.5, p = 2 × 10−16), with both M1 and M2 genes showing significantly lower average f compared to all other 
human genes (Tukey’s test, p = 1.00 × 10−8 and p = 3.53 × 10−7, respectively) (Fig. 5A, Supplementary Table S5). 
Because the degree of constraint may depend on gene features unrelated to function (e.g., GC content)49, 50, we 
compared genes in the M1 and M2 modules to gene subsets matched for GC content and length (see methods for 
matching procedures). M1 and M2 genes showed significantly lower f values when compared to the respective 
matched gene sets (Fig. 5B). Finally, we wished to verify whether M1 and M2 genes differ in the level of coding 
sequence constraint compared to genes that display similar evolutionary rates over their entire length (coding 
and non-coding) and across a longer time-frame. We thus used GERP (Genomic Evolutionary Rate Profiling) 
scores to obtain gene sets matched to genes in the M1 and M2 modules. Again M1 and M2 genes displayed lower 
f values (Fig. 5C).
Neanderthal introgression and modern human-specific alleles. Admixture with extinct hominins 
(Neanderthals and Denisovans) resulted in the introgression of archaic alleles into the human gene pool51–53. 
Recent data indicated that genomic regions experiencing strong levels of background selection are depleted in 
Neanderthal ancestry54. Moreover, regions depleted of both Neanderthal and Denisova ancestry are enriched 
for genes expressed in specific brain regions (e.g. the ventral frontal cortex-ventrolateral prefrontal cortex in 
infants and the striatum in adulthood)55. We thus used a Neanderthal introgression map to estimate the aver-
age introgression scores for M1 and M2 genes. These scores were compared to those calculated for all human 
coding genes to determine whether M1 and M2 genes experienced unusual levels of introgression. Significant 
differences among the three groups (M1, M2, and all other genes) were observed for both Europeans and Asians 
(Kruskall-Wallis test, p = 0.032 and = 0.0085, respectively) (Fig. 5D, Supplementary Table S5). Specifically, M1 
genes showed significantly lower levels of introgression compared to all coding human genes in both populations 
(Nemenyi post-hoc test, p = 0.033 and p = 0.0085 for Europeans and Asians, respectively) (Fig. 5D). The same 
results were obtained when M1 genes were compared to gene sets matched in GC content and length or GERP 
scores (Fig. 5E and F).
However, this finding does not imply that introgression did not occur at these genes. In fact, 8 genes in either 
M1 or M2 had an introgression score higher that the 95th percentile value calculated on the distribution of all 
human coding genes (Supplementary Table S5). These genes were further analyzed by identifying regions with a 
Figure 3. Domain representation of positively selected genes. Sites showing evidence of positive selection are 
mapped onto the domain representation of the proteins and colour-coded as follows: orange, positively selected 
sites on the mammalian branch; green, positively selected sites on the sauropsidan branch; black, positively 
selected sites in the mammalian phylogeny. Selected sites in the human, chimpanzee or gorilla lineages are 
highlighted in cyan, yellow and violet, respectively. Positions refer to human sequences (Supplementary 
Table S1). Domain names and functions are reported in the legend. Black stars indicate missense mutations 
associated to ASD, ID, SCZ, and other neurodevelopmental disorders33, 79, 82, 120–123.
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high introgression score and by searching, within these regions, for archaic variants (i.e. homozygous positions 
in the Neanderthal sequence where the archaic allele is present in populations of non-African ancestry only). 
Among archaic SNPs, we searched for those with likely functional effects by identifying brain eQTLs (via the 
BRAINEAC database). One ~108 kb haplotype defined by 20 archaic SNPs in full linkage disequilibrium was 
found to span SYNGAP1 and nearby genes (Fig. 6). Network analysis of these variants identified three major 
haplotypes one of which is shared by Neanderthals, Denisovans, and by a small fraction of non African mod-
ern human chromosomes (Fig. 6). Five variants defining the introgressed haplotype are reported as eQTLs in 
BRAINEAC. However, these SNPs do not represent eQTLs for SYNGAP1, but rather modulate the expression of 
two nearby genes: CUTA (CutA divalent cation tolerance homolog protein) and PHF1 (PHD finger protein 1). 
Specifically, for both genes the archaic SNPs are associated with higher expression level in different brain areas 
(Fig. 6).
The availability of archaic hominin sequence data also allows the identification of modern human alleles – i.e., 
alleles that were absent in Neanderthals and Denisovans but display high frequency in modern human popu-
lations. We used a catalog of modern-human-specific sites to search for variant located in M1 or M2 genes56. 
Several modern alleles were identified and these were filtered by requiring that: (i) both the Altai Neanderthal and 
the high-coverage Denisova sequence were homozygous for the ancestral allele, and (ii) the variants were either 
eQTLs in brain or mapped to putative regulatory regions for brain expression (as assessed by open chromatin, 
histone modifications or DNAse hypersensitivity, see methods). We next assessed whether variants passing these 
criteria (n = 138) were located in regions that experienced positive selection in early modern human populations. 
To this aim, we exploited the selection scan score (S) developed by Green and coworkers51. S is negative in regions 
where Neanderthals carry fewer derived alleles than expected based on the allelic configuration in modern pop-
ulations, a scenario consistent with selection in early modern humans. Specifically, we called selected regions in 
M1 and M2 genes as windows of at least 25kb where all SNPs have an S score lower than the 5th percentile (calcu-
lated on the genome-wide distribution of S scores, see methods). A few modern human-specific variants in YY1, 
STAG1, and PIAS1 occurred in putative selected regions (Supplementary Table S6 and Supplementary Fig. S1). 
However, the strongest signals were evident for DYRK1A and TCF4, which showed several modern human var-
iants in long regions of low S (Fig. 7). Indeed, DYRK1A had been identified as a top candidate for early human 
selective events by Green and coworkers51. As expected, given the selection criteria of high frequency in modern 
human populations, the derived alleles of DYRK1A and TCF4 variants are fixed in populations of Asian ancestry, 
while they display very high frequency in Europeans and Africans (Supplementary Table S6).
Discussion
We took advantage of genetic diversity data for human populations, archaic hominins and great apes, as well as of 
genomic information for vertebrates to provide insight into the evolution of two gene modules involved in neu-
rodevelopmental disorders. We focused in particular on 68 genes which, despite not being an exhaustive catalog 
of genetic risk loci for ASD and ID, were previously shown to represent functional modules enriched of de novo 
mutations in probands29. Whereas module 2 is rather homogeneous in terms of protein function, M1 comprises 
diverse functional categories, including genes involved in the ubiquitin pathway and in cancer (see below), in line 
with previous observations57, 58.
We first assessed whether M1 and M2 genes evolved under different selective pressure on the branches leading 
to Mammalia and to Sauropsida. This was achieved by using branch-site tests, which were shown to be robust to 
the large evolutionary distances of the vertebrate phylogeny59. Although lineages showing high cognitive skills 
are reported both among mammalian and bird species, mammals are generally believed to have acquired higher 
prosocial skills compared to non-mammalian vertebrates60, 61. For instance, prosocial behaviors have been doc-
umented in primates and rodents60, 61. Conversely, experiments in crows, birds that display high cognitive abili-
ties10, failed to reveal other-regarding preferences and reciprocity11, 12.
M7-M8 M8a-M8
Sites (aa)c−2ΔlnLa p valueb −2ΔlnLa p valueb
M1
MDM2 33.357 1.142 × 10−7 4.683 3.047 × 10−2 I347, S348, T371, I372, I388, F420, V432
MECP2 (Reg1) 11.692 5.782 × 10−3 7.593 5.860 × 10−3 —
MYC 18.374 1.023 × 10−4 16.927 7.768 × 10−5 V185, I429
SMARCC2 55.960 1.411 × 10−12 18.189 2.000 × 10−5 S1049
UIMC1 147.783 1.623 × 10−32 87.994 6.566 × 10−21 S25, L152, T270, A424, F456, T604, S637, A648
M2
GRIN2A 82.719 2.181 × 10−18 58.105 2.485 × 10−14 V329, P1150
MAP1A 189.749 1.252 × 10−41 147.643 5.678 × 10−34 P1065, D1080, A1115, H1259, T1277, Y1388, A1456, A1463, V1506, V1806, H2336, C2357
SYNGAP1 (Reg1) 33.228 1.218 × 10−7 17.161 3.433 × 10−5 —
Table 2. Likelihood ratio test (LRT) statistics for models of variable selective pressure among sites in the 
mammalian phylogeny (codon frequency: F3 × 4). Models: M7 is a null model that assumes that 0 < ω < 1 
is beta distributed among sites; M8 (positive selection model) is the same as M7 but also includes an extra 
category of sites with ω > 1. M8a is the same as M8, except that the 11th category cannot allow positive selection, 
but only neutral evolution. a2ΔlnL: twice the difference of the natural logs of the maximum likelihood 
of the models being compared. bp values are FDR corrected. cPositions refer to the human sequence (see 
Supplementary Table 1, Supplementary material).
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We did not observe a substantial difference in selective pressure in Mammalia compared to Sauropsida, and 
in most cases we detected evidence of episodic positive selection for the same genes in both lineages, suggesting 
that coding variants in these genes do not represent major drivers of social skill differences among Vertebrata. 
However, sites that experienced episodic positive selection in either the mammalian or the sauropsidan branch 
were detected in several genes with clear involvement in ASD or ID. In this respect it is worth noting that 
branch-site tests have low false positive rates but also limited power to detect specific sites targeted by selection30. 
Moreover, we applied a conservative criterion by requiring that selected sites were identified by at least two meth-
ods. These factors are likely to have resulted in an under-estimation in the number of positively selected sites, 
and in some instances no site was detected despite a significant LRT. We thus extended evolutionary analysis to 
a larger mammalian phylogeny and we used a population genetics-phylogenetic approach to more specifically 
investigate the strength of selection acting on humans and great apes.
Figure 4. Population genetics-phylogenetics analysis in human, chimpanzee and gorilla lineages. Violin plot of 
selection coefficients for the the human, chimpanzee and gorilla lineages (median, red dot; interquartile range, 
black bar) for M1 and M2 genes. The gray shading denotes different degree of constraint based on selection 
coefficients. Black stars indicate genes with lineage-specific positively selected sites.
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Based on the number of detected sites and on coding sequence length, the genes showing the strongest sig-
nals of positive selection in Mammalia and in Hominindea were MDM2 and UIMC1. Both genes are highly 
expressed in the testis (http://www.gtexportal.org/) and have been implicated in cancer62, 63. MDM2 encodes a 
nuclear-localized E3 ubiquitin ligase that mediates the degradation of p53 and RB162 in a proteasome-dependent 
and ubiquitin-independent manner64. The protein product of UIMC1 (often referred to as RAP80) is a nuclear 
protein involved in the multivalent recognition of polyubiquitin chains (UIMs) that recruits BRCA1 and other 
proteins to DNA damage sites65. Previous works reported that genes involved in cancer and apoptosis, including 
BRCA1 and BRCA2, are common targets of positive selection66, 67. In line with these data, we also found selected 
sites in MYC, RB1, and TRAF2, genes which play a role in cancer and/or apoptosis (Fig. 4, Table 3). An interesting 
possibility to explain these findings is selfish spermatogonial selection: variants that increase the rate of cell divi-
sion or decrease the probability of apoptosis in a given germline cell are favored, irrespective of the fitness effect 
on the embryo68. Indeed, male germ-line-selective advantage has previously been described for mutations in 
other genes involved in cancer (e.g. FGFR2, FGFR3, RET, PTPN11) that cause congenital disorders with paternal 
age effect69–77. In this respect, it is worth noting that missense mutations in probands with ASD were described 
in MDM2 and UIMC1 regions where positively selected sites are also located (Fig. 3). Intriguingly, the MDM2 
region where the selected sites and the ASD mutation map is necessary for USP2a binding, which results in 
MDM2 stabilization and p53 degradation78. The MDM2 mutation detected in the ASD proband was of paternal 
origin (no information is available for the UIMC1 change)79. Indeed, recent analyses reported a strong paternal 
bias in de novo ASD point mutations and a correlation between mutation number and paternal age79. Given that a 
substantial overlap exists in risk genes for autism and for cancer58, it will be important to assess whether a subset 
of mutations associated with ASD derive from selfish spermatogonial selection.
MDM2 and UIMC1 were identified as top risk genes for ASD, although the contribution of specific variants 
remains to be validated. Based on functional data, MDM2 is a very promising candidate. In mouse neurons, 
MDM2 ubiquitinates DLG4 (also known as PSD-95) and participates with other ASD-associated genes to the 
process of experience-dependent synapse elimination80. PSD-95 is a membrane-associated guanylate kinase 
(MAGUK) acting as scaffold for junctional surface complexes and actin cytoskeleton, thus contributing to the 
organization of the postsynaptic density (PSD)81. Whereas the evolutionary history of DLG4 seems to be dom-
inated by purifying selection, three of its direct interactors (GRIN2A, SYNGAP1, and MAP1A, in addition to 
Gene Lineage Codon
Ancestral 
AA
Derived 
AA Pra
GORASP2
Human 257 Ala Thr 0.901
Gorilla 247 Pro Ser 0.988
HSPA4 Human 778 Ile Thr 0.982
MDM2
Human 283 Arg Gln 0.960
Human 432 Met Val 0.961
Gorilla 413 Ser Cys 0.948
MYC
Human 369 Asp Val 0.874
Chimp 224 Ala Pro 0.872
PSMA7 Human 216 Pro Ser 0.911
RAB2A Gorilla 197 Thr Ser 0.752
RB1 Human 233 Val Met 0.947
SETD5
Chimp 421 Thr Ala 0.759
Chimp 563 Pro Ala 0.760
SMARCC1
Human 117 Thr Ala 0.850
Human 437 Pro Leu 0.851
SYT1 Gorilla 420 Val Ile 0.902
TRAF2
Human 237 Ala Val 0.963
Human 258 Ser Leu 0.963
Human 373 Thr Ile 0.935
Gorilla 221 Ile Val 0.781
UIMC1
Chimp 429 Arg Gly 0.958
Chimp 439 Ala Thr 0.960
Chimp 511 Arg His 0.911
Chimp 597 Ser Gly 0.974
Chimp 601 Cys Phe 0.974
Gorilla 16 Asn Ile 0.913
Gorilla 62 Thr Ala 0.894
Gorilla 502 Gln His 0.764
Gorilla 581 Ser Cys 0.775
Table 3. Positively selected sites in the human, chimpanzee and gorilla lineages. aPosterior probability of γ ≥ 1 
as detected by gammaMap.
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MDM2) showed evidence of positive selection on the mammalian branch. Mutations in GRIN2A have been asso-
ciated with a variety of neurological disorders82. NMDA receptors are both ligand-gated and voltage-dependent, 
and play a fundamental role in brain development and function. Interestingly, three of the four positively selected 
Figure 5. Degree of selective constraints and Neanderthal ancestry of M1 and M2 genes. (A) Swarm plot 
representation of f values for M1 (blue), M2 (green), and all other human RefSeq genes (Supplementary 
Table S5). Tukey’s post-hoc test p values are reported. Genes showing evidence of positive selection in the 
mammalian phylogeny are in red. (B) Boxplot representation of f values for M1 and M2 genes compared to gene 
sets matched for GC content and length (M1 reference set (blue border) = 1344 genes, M2 reference set (green 
border) = 84 genes) or (C) GERP score (M1 reference set (blue border) = 649 genes, M2 reference set (green 
border) = 126 genes). Student’s t test p values are reported. (D) Comparison of the average introgression score 
in European (EUR) and East Asian (ASN) population for M1, M2 and all RefSeq genes. Nemenyi’s post-hoc 
test p values are reported. (E) Comparison of average introgression scores between M1/M2 genes and gene sets 
matched by GC content and length or (F) GERP scores. Wilcoxon Rank-Sum test p values are reported.
www.nature.com/scientificreports/
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sites detected in GRIN2A are in the intracellular CTD domain, which contains the terminal conserved -ESDV- 
sequence required for the interaction whit DLG483. This domain primarily experienced diversification during the 
Figure 6. Neanderthal introgression at the SYNGAP1 locus. (A) The genomic region containing SYNGAP1 is 
shown within the UCSC Genome Browser view. The 20 archaic variants defining the introgressed Neanderthal 
haplotype are reported. Relevant annotation tracks are also shown. SNPs reported as eQTLs in BRAINEAC are 
in green. (B) Haplotype analysis reconstructed through a median-joining network of SYNGAP1 introgressed 
SNPs. Each node represents a different haplotype, with the size of the circle proportional to frequency. IDs for 
SNPs defining the haplotype shared by Neanderthals, Denisovans, and a small fraction of non African modern 
humans are listed on the branch. (C) Box plot representation of CUTA and PHF1 genes expression levels 
stratified by genotype status at rs4231. Data derive from the BRAINEAC data collection (THAL, thalamus; 
HIPP, hippocampus; PUTM, putamen; WHMT, white matter; CRBL, cerebellum; TCTX, temporal cortex).
www.nature.com/scientificreports/
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two rounds of gene duplication that led to the generation of four GluN2A-D paralogs in Vertebrata84. CTD diver-
sification led to the development of subunit-specific functions in the regulation of vertebrate behavior, depending 
on the differential modulation of synaptic signaling. In particular, the CTDs of GRIN2A and GRIN2B (GluN2B) 
differentially regulate behavioral phenotypes in mice (e.g. impulsivity and anxiety)85. This difference is partially 
mediated by the differential binding to intracellular signaling proteins85. Reverse-genetics experiments will be 
required to evaluate whether variation at the positively selected sites modulate phenotype traits in mammals or 
NMDAR biochemical properties.
With respect to SYNGAP1 and MAP1A, both encoding abundant proteins in the PSD, very different numbers 
of positively selected sites were observed. Several sites were detected in MAP1A, whereas only few are located in 
SYNGAP1. This difference is likely to reflect both the strength of positive selection acting on these genes and the 
relevance of functional/structural constraint in limiting the space accessible for amino acid substitutions. At least 
in Homininae and in human populations, SYNGAP1 and MAP1A display different levels of constraint. MAP1A is 
relatively tolerant to amino acid substitutions compared to other genes in the M1 and M2 modules (Fig. 5). This 
observation does not imply that the gene is dispensable, and loss of MAP1A function causes neurodegeneration 
in mice86, but some changes that do not abolish protein function can likely be tolerated. In this respect, it is worth 
noting that de novo mutations in MAP1A have not been unequivocally associated to ASD or ID, but a population 
genetics study indicated that the gene is significantly enriched in rare missense variants when ADS and SCZ 
subjects are compared to controls87. This observation, together with our data, suggests that mildly deleterious var-
iants in MAP1A segregate at low frequency and contribute to the genetic susceptibility to ASD/SCZ. SYNGAP1, 
on the contrary, appears to be strongly constrained and only two selected sites were identified. Interestingly, one 
of them is located in the C2 domain. De novo mutations in SYNGAP1 are thought to represent a relatively com-
mon cause of ID with epilepsy, and most detected changes in affected subjects are loss-of-function mutations33. 
Figure 7. DYRK1A and TCF4 modern human alleles. Modern-human-specific SNPs and their location in 
DYRK1A (A) and TCF4 (B) are shown within the UCSC Genome Browser view. S scores are shown in red. The 
horizontal black line represents the 5th percentile of S score. Relevant annotation tracks from the Roadmap 
Epigenomics Data Complete Collection at Wash U Viz Hub are also shown, filtered for brain tissues only.
www.nature.com/scientificreports/
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Five missense variants have been reported to date as pathogenic and two of them are located in the C2 domain, 
indicating that amino acid substitutions in this region potentially modulate cognitive phenotypes33.
Whereas the level of constraint was similarly high at M1 and M2 genes, only genes in the M1 module were 
found to display significantly lower Neanderthal introgession scores compared to the reference gene set. The rea-
son(s) why genomic regions experiencing background selection tend to be depleted in Neanderthal ancestry is a 
still matter of debate54, 88. Both epistatic reproductive incompatibilities between humans and Neanderthals and 
increased mutation load due to reduced fitness in Neanderthals have been proposed as possible explanations54, 88. 
Disentangling these alternatives is beyond the scope of our work. As for the reason why the M2 module did not 
show reduced Neanderthal introgression, we note that it comprises few genes, and most of these tend to display 
low introgression scores. The high average score of the M2 module is largely due to few outliers in CEU (GRIN2B, 
SYNGAP1, and KCNH1) and ASN (MAPK1) (Supplementary Table S5).
All the archaic SNPs we identified in genes with high introgression scores were located in non-coding regions. 
Because eQTLs for cerebellum and temporal cortex were found to be over-represented among introgressed 
SNPs89, we checked our archaic variants against the BRAINEAC database. BRAINEAC provides information 
on eQTLs from 12 brain regions obtained from 134 neurologically healthy individuals of European descent90. 
Results showed the presence of a SYNGAP1 introgressed haplotype shared by Neanderthals, Denisovans, and by 
a small fraction of non African modern humans. Five SNPs in the haplotype are reported as eQTLs for two nearby 
genes, CUTA and PHF1. Although these genes are involved in different processes, both regulate the signaling of 
molecules acting as neurotransmitters, namely acetylcholyne and γ-aminobarbituric acid (GABA). CUTA affects 
the folding, oligomerization, and secretion of acetylcholynesterase91, whereas the PHF1b isoform promotes the 
transcription of GABRB1, which encodes GABA type A receptor (GABAAR); this results in the regulation of 
GABA-mediated neurotransmission in the central nervous system, in particular in neocortical and hippocampal 
neurons92. CUTA also modulates the generation of β-amyloid peptides (Aβ), major components of senile plaques 
typical of Alzheimer’s disease93. Specifically, the longest isoform of CUTA interacts with BACE1, a β-secretase 
involved in the generation of Aβ peptides, reducing secretion of neurotoxic molecules. We found that the intro-
gressed allele at rs4231 (C) is associated with an increased expression of CUTA in many brain tissues, suggesting 
a protective effect against neurotoxic β-amyloid plaque generation. It is tempting to speculate that, as both cho-
linergic and GABAergic signaling are finely regulated, changes in the expression levels of CUTA and PHF1 would 
result in alterations of synaptic plasticity94, 95. These data are in line with recent observations whereby introgressed 
alleles are often associated with neurological disorders89 and changes in methylation patterns between modern 
humans and archaic hominins are common at genes involved in neurological and psychiatric diseases96. However, 
it remains to be evaluated whether the introgressed variants we describe entail a phenotypic effect.
Likewise, the functional significance of the modern-human-specific variants we detected in DYRK1A and 
TCF4 is presently unknown. It is also worth mentioning that modern-human-specific alleles are defined on the 
basis of two archaic genomes only. Thus, these alleles may have been present in Neanderthals and/or Denisovans, 
possibly at low frequency, and be unsampled in these two individuals. Alternatively, derived alleles at these sites 
may have existed before the split of humans from archaic hominins and be lost to drift in Neanderthals and 
Denisovans. Nonetheless, the fact that several putative modern alleles in DYRK1A and TCF4 are located in 
regions showing signatures of selection in early humans supports the view that some selective pressure drove 
their frequency increase in modern populations.
Mutations in DYRK1A and TCF4 cause syndromic diseases presenting with microcephaly and intellectual 
disability97–105. For both genes haploinsufficiency is often associated with disease, indicating that adequate 
expression levels of these proteins are essential for neurodevelopment98, 101, 106. Moreover, in the case of DYRK1A, 
over-expression can also be deleterious: the gene is located in the Down syndrome (DS) critical region and its 
copy number alteration may be the underlying mechanism for abnormal brain development in DS107. Thus, 
fine-tuning of DYRK1A expression is central to normal brain development. The putative modern alleles we 
detected in these two genes are located within regions that display chromatin features typical of transcriptional 
enhancers in several brain areas, strongly suggesting a regulatory role on gene expression. These SNPs thus repre-
sent candidates for association with neurodevelopmental disorders, and await experimental validation in future 
studies (eg., by approaches that exploit genetically-manipulated induced pluripotent stem cells).
Methods
Datasets and Databases. We analysed the evolutionary history of 68 genes identified using MAGI, a com-
putational method that simultaneously integrates data of protein-protein interaction and co-expression network 
to identified sets of genes defined “disease modules” enriched in de novo mutation in cases compared to controls29.
In particular, we focused on the two gene sets denoted by Hormozdiari29 as Best Modules (47 genes in M1 and 
21 in M2) (Fig. 1, Supplementary Table S1).
Gene coding sequences were retrieved from the Ensembl (http://www.ensembl.org/index.html) and the 
National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov) databases.
1000 Genomes Phase 1 data for population genetics analysis were retrieved from the dedicated website (http://
www.1000genomes.org/). The marginal probabilities of Neanderthal ancestry for Europeans and Asians were 
retrieved from the Datasets-Neanderthal Introgression (http://genetics.med.harvard.edu/reichlab/Reich_Lab/
Datasets_-_Neandertal_Introgression.htmlgenetics.med)54, whereas the list of “modern-human-specific sites” 
were obtained from Prufer and colleagues56.
Brain eQTLs data were retrieved from the the Brain eQTL Almanac (BRAINEAC) database (www.braineac.
org/)90.
S scores for all SNPs in the genome were retrieved from the UCSC genome browser (table name: Selective 
Sweep Scan (S))51.
www.nature.com/scientificreports/
13Scientific REPORtS | 7: 6116 | DOI:10.1038/s41598-017-06440-4
Evolutionary analysis in vertebrates. We identified orthologous coding sequences in the genome of 33 
species selected to be representative for the Vertebrata subphylum and to include a similar number of mammalian 
and sauropsidan species (Fig. 2, Supplementary Table S2).
Orthology was assessed using the EnsemblCompara GeneTrees database108 and only 1-to-1 orthologs were 
included. Because this database does not include some Sauropsida species (Falco peregrinus, Zonotrichia albicol-
lis, Melopsittaus undulatus, Columba Livia and Alligator mississippiensis), we performed BLAST searches of the 
human coding sequences against the genome of these species using the NCBI BLAST utility. Hits that were not 
consistent with the presence of a single ortholog were removed. SUMO2 and YY1 (M1) were not included in this 
analysis due to the impossibility to reach a substantial number of orthologs from other species.
Alignments were performed using the RevTrans 2.0 utility109 and manually edited to remove uncertainties in 
proximity of small gaps.
Substitution saturation was checked using Xia’s index implemented in DAMBE110. This test compares a 
entropy-based index of saturation (Iss) with a critical value (Iss.c). If Iss is significantly lower than Iss.c, sequences 
have not experienced substitution saturation. No evidence of significant saturation was obtained for any 
alignment.
All alignments were screened for the presence of recombination breakpoints using GARD111. GARD evaluates 
the statistical significance of putative breakpoints through Kishino-Hasegawa (HK) tests. A breakpoint was con-
sidered significant if its p values were lower that 0.01.
The branch-site likelihood ratio tests (models MA and MA1) implemented in the PAML suite37 were used to 
test the mammalian and sauropsidan branches.
The total tree length for the gene alignments ranged from 3.17 to 18.15; these values are within a good accu-
racy range for codeml sites models112. We used two different codon frequencies model: the F3 × 4 model (codon 
frequencies estimated from the nucleotide frequencies in the data at each codon site) and the F61 model (fre-
quencies of each of the 61 non-stop codons estimated from the data)37. An FDR correction was applied to account 
for multiple hypothesis testing, as suggested31. Positively selected sites were identified using two different meth-
ods: the Bayes Empirical Bayes (BEB) analysis from MA (with a cutoff of 0.90) and the Mixed Effects Model of 
Evolution (MEME) (with the default cutoff of 0.1)34.
GARD and MEME analyses were performed either through the DataMonkey server113 (http://www.datamon-
key.org) or run locally114.
Evolutionary analysis in the mammalian phylogeny. Coding sequences were retrieved for at least 
60 mammalian species, including Metatheria and Eutheria (Fig. 2, Supplementary Table S2). Sequences were 
checked for orthology, aligned, and screened for recombination as described in the previous section.
To detect positive selection, we used the codeml NSsite models from PAML. Selection was declared if both 
neutral models (M8a, M7) were rejected in favor of the positive selection model (M8) using the F3 × 4 and F61 
codon frequency models.
When the likelihood ratio test indicated the action of positive selection, we applied three different methods 
to identified individual selected sites: BEB analysis (from M8 with a cutoff of 0.90)112, the Random effects likeli-
hood (REL, with a cutoff of 50), and the Fast Unconstrained Bayesian AppRoximation (FUBAR, with a cutoff of 
0.90). To limit false positives, we considered a site as positively selected if it was detected by at least two different 
methods.
Population genetics-phylogenetics analysis in the human, chimpanzee, and gorilla line-
ages. Human data derive from the 1000 Genomes Phase 1 Project database for European (CEU), Yoruba 
(YRI), and Chinese (CHB). For chimpanzees and gorillas, we used SNP information from 25 and 27 individuals, 
respectively115.
Ancestral sequences were reconstructed by parsimony from the human, chimpanzee, orangutan, and macaque 
sequences.
Analyses were performed with gammaMap, that evaluates intra-specific variation and inter-specific diversity 
to estimate, along coding regions, the distribution of population-scaled selection coefficients (γ). In this frame-
work, γ is defined as  2PNes, where P is the ploidy, Ne is effective population size, and s is the fitness advantage of 
any amino acid-replacing derived allele.
In the analysis, we assumed θ (neutral mutation rate per site), k (transitions/transversions ratio), and T 
(branch length) to vary among genes following log-normal distributions, whereas p (probability of adjacent 
codons to share the same selection coefficient) following a log-uniform distribution. For each gene we set the 
neutral frequencies of non-STOP codons (1/61). For selection coefficients we considered a uniform Dirichlet 
distribution with the same prior weight for each selection class. For each gene we run 100,000 iterations with 
thinning interval of 10 iterations.
Purifying selection in humans. The strength of purifying selection was estimated using SnIPRE48, a tool 
that relies on the comparison of polymorphism and divergence data from synonymous and non-synonymous 
sites within genes. SnIPRE uses a generalized linear mixed model to represent the genome-wide variability among 
categories of mutations and to estimate its functional consequence. We estimated the degree of selective con-
straints at each gene using the f parameter, which is the proportion of non-synonymous mutation that are not 
deleterious.
The f parameter was estimated for each gene of the M1 and M2 modules and for all RefSeq autosomal coding 
human genes used as reference (Supplementary Table S5).
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To evaluate divergence within genes, we used the liftOver tool to convert human GRCh37/hg19 genome coor-
dinates to Pan troglodytes (CGSC 2.1.3/PanTro3) coordinates; we selected only genes that mapped on chimpanzee 
genome (n = 14805).
Specific reference gene sets were selected for both the M1 and M2 modules. These sets were obtained by con-
trolling for base composition and gene length or gene conservation. We used a treshold of ±10% for each feature 
and a matching procedure similar to that reported by Enard and colleagues116. Thus, for each M1 and M2 gene, we 
searched for all matching genes whose GC content and length or GERP score differed less or more than 10% from 
those of the M1/M2 gene. GERP scores were obtained from UCSC genome browser (table name: GERP Scores 
for Mammalian Alignments)117.
Neanderthal introgression and haplotype analysis. To investigated the introgression from archaic 
hominins, we used the probabilities of Neanderthal ancestry calculated for each SNP of the 1000 Genomes Project 
dataset54. We used the inferred Neanderthal ancestry at each allele in European (CEU, GBR, FIN, IBS and TSI) 
and Asian (CHB, CHS, and JPT) populations54. The introgression summary score was calculated for each gene by 
averaging the marginal probabilities of Neanderthal ancestry for all SNPs of the gene.
We thus estimated the average introgression scores for M1 and M2 genes, as well as for all RefSeq coding 
human genes. We analyzed in detail M1 and M2 genes having an average introgression score higher that the 95th 
percentile value based on the distribution of all genes. Introgressed regions were defined based on the presence of 
archaic variants (i.e. homozygous positions in the Neanderthal sequence where the archaic allele is only present 
in populations of non-African ancestry) with an high introgression score (i.e. higher than 95th percentile). The 
introgressed regions were then analyzed for the presence of brain eQTLs (via the BRAINEAC database) and 
median-joining networks118 were constructed to infer haplotype genealogy. For Network analyses we used CEU, 
YRI, and CHB SNPs with genotype information from an Altai Neanderthal and a Denisovan individuals52, 56.
Modern human alleles and selection in early modern humans. A list of modern human-specific 
sites - i.e. positions where the Denisova or Altai Neanderthal sequences display the ancestral allele, whereas most 
modern humans carry the derived allele - were retrieved from a previous study56. We filtered these variants by 
requiring that both the Altai Neanderthal and the Denisova sequences were homozygous for the ancestral allele 
and the variants were either eQTLs in brain or mapped to putative regulatory regions for brain expression. For 
this purpose, we used information from the HaploReg database119 to scan for variants in regulatory regions as 
assessed by open chromatin, histone modifications, or DNAse hypersensitivity.
To assess whether a moder human-specific SNPs were located in genomic regions that experienced positive 
selection in early modern humans, we exploited the selection scan score (S) developed by Green et al.51. A nega-
tive S score identifies a region where Neanderthals carry fewer derived alleles than expected based on the allelic 
status in modern populations. S scores were retrieved for all SNPs in the genome and the genome-wide distribu-
tion of S was calculated. We then searched for modern-human-specific variants in M1/M2 genes that were located 
in a region of at least 25 Kb where all SNPs have an S score lower than the 5th percentile in the genome-wide 
distribution.
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